Substrate
Topic

mrna-technology

2 stories related to this topic, newest first.

Moderna Collaborates on Preclinical mRNA Hantavirus Vaccine in South Koreabenzinga.com
world5 hrs agoDeveloping

Moderna Collaborates on Preclinical mRNA Hantavirus Vaccine in South Korea

Newsweek reported that Moderna is involved in early-stage development of an mRNA vaccine targeting hantaviruses causing hemorrhagic fever with renal syndrome. The preclinical project, announced in 2024 by Korea University’s Vaccine Innovation Center, focuses on Asian strains and…

Newsweek
globalresearch.ca
2 sources
Moderna mRNA Flu Vaccine Outperforms Standard Shot in Phase 3 TrialUsa Today
health7 hrs agoFraming55Framing risk55/100Rewrite largely reports trial data neutrally but inherits mild valence skew and lede misdirection by foregrounding the 'beats standard shot' victory frame and regulatory drama over balanced efficacy/safety substance.Click to jump to full framing analysis

Moderna mRNA Flu Vaccine Outperforms Standard Shot in Phase 3 Trial

Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…

Usa Today
Nbc News
2 sources